ChemicalBook > Product Catalog >Organic Chemistry >Heterocyclic Compounds >7-Bromoquinazoline

7-Bromoquinazoline

7-Bromoquinazoline Suppliers list
Company Name: J & K SCIENTIFIC LTD.  
Tel: 18210857532 18210857532
Email: jkinfo@jkchemical.com
Company Name: Shijiazhuang Sdyano Fine Chemical Co., Ltd.  
Tel: 0311-89250318 13582355795
Email: master@sjzsdyn.com
Company Name: Carbott PharmTech Inc.  
Tel: 0535-6385396
Email: info@carbottpharm.com
Company Name: Capot Chemical Co., Ltd  
Tel: +86 (0) 571 85 58 67 18
Email:
Company Name: Pure Chemistry Scientific Inc.  
Tel: 001-857-928-2050 or 1-888-588-9418
Email: sales@chemreagents.com

7-Bromoquinazoline manufacturers

  • 7-Bromoquinazoline
  • 7-Bromoquinazoline pictures
  • $8.80
  • 2019-08-06
  • CAS:89892-22-8
  • Min. Order: 1KG
  • Purity: 97%-99%
  • Supply Ability: 100kg
7-Bromoquinazoline Basic information
Product Name:7-Bromoquinazoline
Synonyms:7-BROMO-QUINAZOLINE;7-Bromoquizoline;Quinazoline, 7-bromo-
CAS:89892-22-8
MF:C8H5BrN2
MW:209.04
EINECS:
Product Categories:CHIRAL CHEMICALS
Mol File:89892-22-8.mol
7-Bromoquinazoline Structure
7-Bromoquinazoline Chemical Properties
Boiling point 304.3±15.0 °C(Predicted)
density 1.656±0.06 g/cm3(Predicted)
storage temp. Sealed in dry,Room Temperature
pka3.60±0.70(Predicted)
AppearanceWhite to yellow Solid
Safety Information
Risk Statements 41
Safety Statements 26-39
MSDS Information
7-Bromoquinazoline Usage And Synthesis
Uses7-Bromoquinazoline has been used as a reactant in the preparation of N1-(5-(heterocyclyl)-thiazol-2-yl)-3-(4-trifluoromethylphenyl)-1,2-propanediamines as AKT/PKB inhibitors for cancer treatment.
Synthesis
Quinazoline

253-82-7

7-Bromoquinazoline

89892-22-8

General procedure for the synthesis of 7-bromoquinazoline from quinazoline: Step A: N-bromosuccinimide (NBS, 2.13 g, 11.9 mmol) was slowly added to a solution of concentrated sulfuric acid (appropriate amount) of compound 214 (quinazoline, 1.04 g, 7.99 mmol) at room temperature. The reaction mixture was stirred continuously at room temperature for 16 h. The reaction progress was monitored by thin layer chromatography (TLC, unfolding agent: 5% methanol/dichloromethane) to confirm the completion of the reaction. Subsequently, the reaction mixture was carefully poured into crushed ice (~50 mL) and the pH was adjusted to neutral (pH=7) using ammonium hydroxide solution. The resulting slurry was continued to be stirred at 0 °C for 1 h. The solid product was then collected by filtration and washed with ice-cold water (3 x 30 mL). Finally, purification by silica gel column chromatography (SiO2, eluent: 5% methanol/dichloromethane) afforded the target compound 215 (7-bromoquinazoline) as a beige solid with a yield of 0.53 g in 32% yield. Product characterization: 1H NMR (400 MHz, DMSO-d6) δ 9.57 (s, 1H), 9.32 (s, 1H), 8.46 (d, 1H), 8.14 (dd, 1H), 7.96 (d, 1H).

References[1] Patent: WO2008/82487, 2008, A2. Location in patent: Page/Page column 106
[2] Synthesis, 2002, # 1, p. 83 - 86
7-Bromoquinazoline Preparation Products And Raw materials
Raw materialsQuinazoline
Tag:7-Bromoquinazoline(89892-22-8) Related Product Information
Cefazolin sodium salt Cefazolin Quinazoline 5-Methyl-2-phenyl-1,2-dihydropyrazol-3-one 7-BroMoquinoline-8-carboxylic acid 7-broMoquinoline-3-carbaldehyde 7-BroMoquinoline-2-carboxylic acid ethyl 7-bromoquinoline-2-carboxylate 7-broMoquinolin-3-aMine Ethyl 7-broMoquinoline-3-carboxylate 7-Bromoquinazolin-2(1H)-one 7-Bromoquinoline-3-carboxylic acid 6-Bromoquinazolin-4-ol Oxymetazoline hydrochloride 7-Bromo-4-chloroquinazoline 6-Bromo-2,4(1H,3H)-quinazolinedione 6-Bromo-quinazolin-4-ylamine 5-Bromo-quinazoline-2,4-diamine